Stem CellsKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsStem Cell TransplantationHematopoietic Stem CellsGraft RejectionHematopoietic Stem Cell TransplantationEmbryonic Stem CellsChemotherapy, AdjuvantAdult Stem CellsCyclosporineTacrolimusTransplantation, HomologousHeart TransplantationTreatment OutcomePluripotent Stem CellsGraft SurvivalTransplantationStem Cell NicheLung TransplantationLiver TransplantationTime FactorsTransplantsNeural Stem CellsBone Marrow TransplantationMycophenolic AcidInduced Pluripotent Stem CellsOrgan TransplantationCell DifferentiationCombined Modality TherapyMesenchymal Stem Cell TransplantationTissue DonorsMultipotent Stem CellsPostoperative ComplicationsAntineoplastic AgentsCytomegalovirus InfectionsStem Cell FactorMesenchymal Stromal CellsTransplantation, AutologousImmunosuppressionCyclophosphamideCisplatinFollow-Up StudiesImmunocompromised HostSurvival AnalysisRetrospective StudiesDoxorubicinSurvival RatePrognosisBK VirusCell LineageProspective StudiesDisease-Free SurvivalPolyomavirus InfectionsHematopoietic Stem Cell MobilizationTransplantation ImmunologyStem Cell ResearchDrug Administration ScheduleCells, CulturedCell ProliferationPlant StemsDrug MonitoringFetal Stem CellsEtoposideRisk FactorsRecurrenceKidney Failure, ChronicCyclosporinsBreast NeoplasmsNeoadjuvant TherapyCytomegalovirusGraft vs Host DiseaseBronchiolitis ObliteransNeoplasmsNeoplastic Stem CellsHistocompatibility TestingBiopsyBiological MarkersFlow CytometryBone Marrow CellsPeripheral Blood Stem Cell TransplantationHeart-Lung TransplantationSirolimusTransplantation ConditioningNeoplasm StagingLiving DonorsLymphoproliferative DisordersAntilymphocyte SerumTablets, Enteric-CoatedLiver FailureHematologic NeoplasmsLung NeoplasmsPostoperative PeriodGanciclovirKidneyCalcineurinMethotrexateGingival OvergrowthAntigens, CD34